(Q40729349)

English

Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors (English)

1 reference

Europe PubMed Central

23 September 2017

author name string

Hong Xiang

1

1 reference

Europe PubMed Central

23 September 2017

Judith A Fox

2

1 reference

Europe PubMed Central

23 September 2017

Klara Totpal

3

1 reference

Europe PubMed Central

23 September 2017

Mina Aikawa

4

1 reference

Europe PubMed Central

23 September 2017

Kelly Dupree

5

1 reference

Europe PubMed Central

23 September 2017

Dominick Sinicropi

6

1 reference

Europe PubMed Central

23 September 2017

John Lowe

7

1 reference

Europe PubMed Central

23 September 2017

Enrique Escandón

8

1 reference

Europe PubMed Central

23 September 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

21

1 reference

Europe PubMed Central

23 September 2017

3611-3619

1 reference

Europe PubMed Central

23 September 2017

22

1 reference

Europe PubMed Central

23 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205449

0 references

Apoptosis control by death and decoy receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

APO2 ligand: a novel lethal weapon against malignant glioma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53 and bcl-2 expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Apoptosis and cancer drug targeting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Dr. Josef Steiner Cancer Research Prize Lecture: the role of physiological cell death in neoplastic transformation and in anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

p21Waf1/Cip1 acts in synergy with bcl-2 to confer multidrug resistance in a camptothecin-selected human lung-cancer cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

21 January 2018

Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

7 January 2021

based on heuristic

inferred from DOI database lookup

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of p21Waf1/Cip1 by TNFα requires NF-κB activity and antagonizes apoptosis in Ewing tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacokinetic trial of weekly CPT-11

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

7 January 2021

based on heuristic

inferred from DOI database lookup

Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

7 January 2021

based on heuristic

inferred from DOI database lookup

Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205449

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1205449

1 reference

Europe PubMed Central

23 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40729349&oldid=1905208219"